ArticleBMC infectious diseases2026
Burden of diarrheal diseases among children under five in East Africa, 2000-2023: insights from the global burden of disease 2023 study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiarrheal disease remains a leading cause of under-five mortality in East Africa. However, comprehensive contemporary comparative analyses across countries remain limited. This study quantifies the disease burden and temporal trends using the Global Burden of Disease (GBD) 2023 estimates.
methodsWe extracted the incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) for diarrheal diseases among children under five across 12 East African countries (2000–2023) from the GBD Results Tool. We analyzed the temporal trends, country-level variations, and DALYs attributable to water, sanitation, and hygiene (WASH) risk factors using descriptive analysis and trend visualization.
resultsMortality declined by 60–87% in high-performing countries (Tanzania, 84%; Rwanda, 88%; Uganda, 82%; Ethiopia, 86%), whereas Somalia, South Sudan, and Madagascar demonstrated minimal improvement (14.7–69.2% decline), representing a 12-fold difference in 2023 mortality rates (Tanzania 36 vs. South Sudan 443 per 100,000). Corresponding DALY reductions ranged from 80 to 87% in improving countries to 15–69% in countries with stalled progress. Age-stratified analysis revealed that neonates experienced minimal decline (15%) compared with older children (60–80%). Males sustained 25–36% higher mortality and DALYs despite convergent incidence and prevalence. The WASH-attributable DALYs ranged from 3,057 per 100,000 (Tanzania) to 37,608 per 100,000 (South Sudan), with unsafe water contributing 70–80% of the burden.
conclusionsEast Africa achieved substantial but profoundly inequitable reduction in diarrheal disease mortality. Achieving SDG 3.2 requires equitable WASH investment, health system strengthening in conflict-affected regions, and integrated multisectoral approaches addressing water access, sanitation, nutrition, and healthcare delivery simultaneously. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.